Remind me about this event in:
Email Address:    

Add this Event to my Outlook Calendar

Web Sponsors

Official Journal Partner

 

Select Biosciences' inaugural Fragment-Based Lead Discovery Summit was a one day symposium designed to present the latest advances within the field. This meeting was one of several one day events that will focus on the drug discovery sector. It will offer attendees the opportunity to minimize time away from the office and travel costs whilst still providing an excellent overview of the sector and an opportunity to network with its key players.

Keynote Speaker

Sir Tom Blundell
Professor and Research Head
University of Cambridge

Agenda Topics:
• NMR Based Fragment Screening Technologies
• The Suitability of SPR Based Fragment Screening

Sponsorship and Exhibition Opportunities
Aaron Woodley, Exhibition Manager
a.woodley@selectbiosciences.com
+44 (0)1787 315129


Confirmed Speakers
Daniela Fattori Chemistry Department Head, Menarini Ricerche
Rod Hubbard Lab Head, University of York
Renate Sekul
CSO, Graffinity
Helena Danielson Professor, Uppsala University
Richard B. Silverman Professor, Northwestern University
Gregg Siegal Professor, Leiden University
Gordon Saxty Medicinal Chemist, Astex Therapeutics
Maurizio Pellecchia Professor, Burnham Institute for Medical Research